Frontlight ResearchEarly access
Trial site
Center for Cancer and Blood Disorders
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Multiple myeloma2 trials
- Myelodysplastic syndromes2 trials
- Myeloproliferative neoplasms2 trials
- Colorectal cancer1 trial
- Immune thrombocytopenia (ITP)1 trial
- Lung cancer1 trial
- Prostate cancer1 trial
- Sickle cell disease1 trial
- Phase
- Phase 24 trials
- Phase 33 trials
- Phase 12 trials
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Cartesian Therapeutics1 trial
- Celgene1 trial
- CSL Behring1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- and 4 more
Running trials
Recruiting
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Multiple myeloma1 recruiting
- Prostate cancer1 recruiting
- Sickle cell disease1 recruiting
Closed trials
Withdrawn
Completed
Terminated
Completed
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026